Galvani E, Mundra P, Valpione S, et al. Low tumour heterogeneity but not mutational burden correlates with response to anti-PD-1 treatment in a mouse model of melanoma. SMR 2017, abstract SMR4-04.
Eigenschappen PET-tracers onderzocht: meerwaarde klinische toepassing 18F-FES bij ER+ mammacarcinoom
jan 2024 | Borstkanker